Sat 17 Oct 2026

Beta version

All official websites of government entities in the Kingdom of Saudi Arabia end with.gov.sa.

Ensure the website is using the HTTPS protocol.

Registered with the Digital Government Authority under number:

Drug Approvals

SFDA Approved Use	Voriconazole, is a broad-spectrum, triazole antifungal agent and is indicated in adults and children aged 2 years and above as follows: •Treatment of invasive aspergillosis. •Treatment of candidaemia in non-neutropenic patients. •Treatment of fluconazole-resistant serious invasive Candida infections (including C. krusei). •Treatment of serious fungal infections caused by Scedosporium spp. and Fusarium spp. Voriconazole should be administered primarily to patients with progressive, possibly life-threatening infections. Prophylaxis of invasive fungal infections in high-risk allogeneic hematopoietic stem cell transplant (HSCT) recipients.